Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
Dropil

Dropil

Trading
22,856 Views
Visit Website
Last screenshot taken on
13 Mar 2020 .
Add to Watchlist
Helping investors net the highest returns, with the lowest risk, requiring the minimum effort, all in one easy to use suite with intuitive reporting, that is the heart of our mission. Harnessing the unique capabilities inherent to cryptocurrency, we are able to bundle numerous additional financial and security benefits with this service, all while making it low friction and easily accessible to the masses. This was the dream, Dropil is the answer.
Investment
Market Stats
General
Website: Visit
White paper: Read
Pre-sale Time: 24 Jan 2018 - 06 Feb 2018
ICO Time: 07 Feb 2018 - 07 Mar 2018
Country: USA
Token info
Ticker: DROP
Platform: Ethereum
Token Type: ERC20
Available for sale: 15,000,000,000 DROP (50%)
Total supply: 30,000,000,000 DROP
Financial
Raised $ 60,000,000
ICO Price: ≈ 0.003168 USD
Accepting: ETH, BTC, LTC, BCH, NEO, XMR, ZEC, DASH
Soft cap: 5,000,000,000 DROP
Hard cap: 10,000,000,000 DROP
Social media
Links: Bitcointalk
Facebook
Twitter
Telegram
Reddit
Youtube
Screenshots taken on 8 Feb 2018
January 2018
ICO Presale begins
February 2018
Dropil ICO goes live<br />
March 2018
ICO Sale Ends<br /> <br /> AI Bot “Dex” Investing Platform goes live<br /> <br /> High Limit short-term investment implementation into platform<br /> <br /> Go live on Multiple Exchanges
April 2018
Cash out Dropil investments into USD on platform implementation<br /> <br /> Push to go live on largest trading exchanges<br /> <br /> Mobile Wallet on Android and App Store
October 2018
Begin discussions with the correct parties to implement Dropil as a long term retirement plan in common careers
Zachary Matar
Founder/Developer
Participates in a number of projects
Jeremy McAlpine
Founder/Developer
Participates in a number of projects
Patrick O'Hara
Head of Marketing
Participates in a number of projects
Alex Gurevich
Head of Design
No participating data
Allie Ursini
Database Analyst
Participates in a number of projects
Medrick Bell
Logistics & Operations
No participating data
Lindsey Reames
Design Specialist
No participating data
Thomas Rost
Risk Management
No participating data

Advisors (0)

ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Upcoming
Vidy
Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.
Upcoming
Invictus Margin Lending
The Invictus Margin Lending Fund offers investors the ability to take advantage of the volatile nature of the cryptocurrency market without risking direct exposure. The fund aims to maximize interest income on USD and USD equivalents with zero anticipated drawdown risk by taking dollar-based positions on margin lending platforms.
Upcoming
Gluon
Gluon’s platform establishes an interconnected network of vehicles where individuals and businesses can monitor, track, tune, and diagnose the issues in them. Not only can customers diagnose their vehicles themselves, order parts, and request bids on repairs, but they can schedule repairs, send/receive payments for services and goods. Consumers can tune their vehicles for optimal performance and/or regulate their use.Repair shops can diagnose vehicles more cost-effectively and accurately order the correct parts. Vehicle service record, repairs, diagnostics, smog tests are all stored in the Gluon secure blockchain based on the Stratis Platform.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.